Application of gambogic acid in preparation of Src inhibitor and medicine for treating liver cancer

A therapeutic drug, gambogic acid technology, applied in the field of anti-tumor, to achieve the effect of inhibiting proliferation and low cost

Inactive Publication Date: 2022-01-21
THE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether gambogic acid is a Src inhibitor or has an inhibitory effect on Src has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of gambogic acid in preparation of Src inhibitor and medicine for treating liver cancer
  • Application of gambogic acid in preparation of Src inhibitor and medicine for treating liver cancer
  • Application of gambogic acid in preparation of Src inhibitor and medicine for treating liver cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1 Molecular kinetics confirmed that vine acid can stably bind to SRC

[0032] Molecular docking and molecular dynamic simulation by molecular docking software Autodock Vina and molecular kinetics software Yasara. The molecular docking simulation found that the binding between SRC and rattanic acid was -8.883 kcal / mol.

[0033] like Figure 1 ~ 3 Distance figure 1 Structural molecular formula for vine acid; figure 2 The three-dimensional ribbon model of the SRC-rattan acid complex and the amino acid residue of the SRC interact with the rattanoya, which exhibits three hydrogen between GLY-346, TYR-342, and MET-343 of SRC and vine acid. key.

[0034] Src-vine acid complex 3-dimensional ribbon model in 0ns and 80ns image 3 As shown, SRC stably appears at the center of the SRC binding site until the MD simulation ends. The root deviation (RMSD) of the SRC protein is stable during 0-80 ns. Left and right fluctuations ( Figure 4 .

[0035] These molecular simulations sho...

Embodiment 2

[0036] Example 2 Surface plasma resonance certificates Direct combination with SRC protein

[0037] In order to further detect the interaction between vine acid and SRC, the present invention further employs the PLEXARRAY HTA100 biomolecular interaction instrument, established a sensor chip with SRC as a target, vine chiline acid, real-time detection vine by flowing different concentrations of small molecule Interaction between yellow acid and SRC. Surface plasma resonance analysis indicates that the vine acid can quickly bind SRC in a concentration dependent manner, and the balanced dissociation constant (kd) value is approximately 1.55 × 10 -6 M. The results of the balanced dissociation showed that the vine acid had strong affinity to the SRC, suggesting the direct binding of the rattangoic acid and SRC ( Figure 5 . This speculates that vine acid is mainly to be directly acting on SRC protein by inhibiting.

Embodiment 3

[0038] Example 3 There was a significant inhibitory effect on cell proliferation of human source hepatoma cells.

[0039] Such as Image 6 As shown in HepG2 and SMMC-7721 cells, the vinegar acid can concentrate dependence inhibiting the cell viability of liver cancer cells, which has concentration dependence, ie 1.25 μm, 2.5 μm, 5 μm to inhibit significant inhibitory liver cancer cells. Expression, the difference was statistically significant (P <0.05), and the half of the rats of vine acid on human source hepatoma cells was 5 μm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of gambogic acid in preparation of a Src inhibitor and medicine for treating liver cancer, and belongs to the technical field of anti-tumor, gambogic acid in the invention is one of active ingredients of dry resin gamboge secreted by a gamboge plant gamboge tree, can effectively inhibit the activity of tyrosine kinase (Src), is relatively low in cost, therefore, the gambogic acid can be used as a promising Src inhibitor drug and can inhibit proliferation of liver cancer cells.

Description

Technical field [0001] The present invention relates to the field of anti-tumor techniques, and in particular, to the application of vine acid in the preparation of SRC inhibitors and the preparation of liver cancer therapeutic drugs. Background technique [0002] Tyrosine kinase SRC (SRC Proto-Oncogene, SRC) is a non-receptor tyrosine kinase, and a large number of studies have shown that the expression or activity of SRC has increased in the development of cancer. SRC participates in maintaining normal intracellular environmentally stable and wide physiological functions. Except for cell proliferation, SRC protein also regulates cell adhesion, invasion, and migration, which is considered to be related to the progression and metastasis of tumors. Further, inhibition of the expression or activity of SRC has an effect of anti-tumor, inhibition of the role of SRC to play anti-tumor. A variety of SRC kinase inhibitors such as Dhazatini, Sassinini have been widely used in a variety of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): A61K31/352A61P35/00A61K36/38
CPCA61K31/352A61P35/00A61K36/38
Inventor刘彬周迎春吴玉婷林凯莉
OwnerTHE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV